Genmab (GMAB) has released an update.
Genmab A/S has successfully concluded its share buy-back program ahead of schedule, repurchasing shares worth DKK 3.5 billion by June 26, 2024, which was initially set to be completed by December 16, 2024. Through the final transactions, the company now holds 2,670,991 treasury shares, representing 4.04% of its total share capital and voting rights. The buy-back was conducted in accordance with the EU Market Abuse Regulation and Safe Harbour rules.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
